Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 862

1.

Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group.

Diabetes Care. 2005 Mar;28(3):533-8.

PMID:
15735183
[PubMed - indexed for MEDLINE]
2.

A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

Diabetes Care. 2004 Jul;27(7):1554-8.

PMID:
15220227
[PubMed - indexed for MEDLINE]
4.

Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR.

Diabetes Care. 2003 Sep;26(9):2598-603.

PMID:
12941725
[PubMed - indexed for MEDLINE]
5.

Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.

Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.

Exp Clin Endocrinol Diabetes. 2009 Sep;117(8):378-85. doi: 10.1055/s-0029-1225337. Epub 2009 Jul 23.

PMID:
19629931
[PubMed - indexed for MEDLINE]
6.

Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study.

Lepore G, Dodesini AR, Nosari I, Trevisan R.

Diabetes Nutr Metab. 2004 Apr;17(2):84-9.

PMID:
15244099
[PubMed - indexed for MEDLINE]
7.

Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.

Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.

Diabetes Technol Ther. 2005 Aug;7(4):587-96.

PMID:
16120030
[PubMed - indexed for MEDLINE]
8.

A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.

Weinzimer SA, Ternand C, Howard C, Chang CT, Becker DJ, Laffel LM; Insulin Aspart Pediatric Pump Study Group.

Diabetes Care. 2008 Feb;31(2):210-5. Epub 2007 Nov 5.

PMID:
17989308
[PubMed - indexed for MEDLINE]
9.

Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.

Alemzadeh R, Parton EA, Holzum MK.

Diabetes Technol Ther. 2009 Aug;11(8):481-6. doi: 10.1089/dia.2008.0124.

PMID:
19698060
[PubMed - indexed for MEDLINE]
10.

Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.

Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.

Diabetes Care. 2009 Jul;32(7):1170-6. doi: 10.2337/dc08-1874. Epub 2009 Apr 23. Erratum in: Diabetes Care. 2009 Oct;32(10):1944.

PMID:
19389820
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.

Weintrob N, Schechter A, Benzaquen H, Shalitin S, Lilos P, Galatzer A, Phillip M.

Arch Pediatr Adolesc Med. 2004 Jul;158(7):677-84.

PMID:
15237068
[PubMed - indexed for MEDLINE]
12.

Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.

Clin Ther. 2009 May;31(5):980-7. doi: 10.1016/j.clinthera.2009.05.010.

PMID:
19539098
[PubMed - indexed for MEDLINE]
13.

Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB; 5-Nations Study Group.

Diabet Med. 2006 Feb;23(2):141-7.

PMID:
16433711
[PubMed - indexed for MEDLINE]
14.

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.

Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.

Diabet Med. 2008 Mar;25(3):326-32. doi: 10.1111/j.1464-5491.2007.02365.x.

PMID:
18307459
[PubMed - indexed for MEDLINE]
15.

Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.

Bode BW.

Clin Ther. 2007;29 Suppl D:S135-44. doi: 10.1016/j.clinthera.2007.12.013.

PMID:
18191065
[PubMed - indexed for MEDLINE]
16.

Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

Diabetes Technol Ther. 2007 Aug;9(4):339-47.

PMID:
17705689
[PubMed - indexed for MEDLINE]
17.
18.

Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.

Bartolo PD, Pellicano F, Scaramuzza A, Sardu C, Casetti T, Bosi E, Miselli V, Brandolini S, Fabbri T, Meandri P, Cannatà F.

Diabetes Technol Ther. 2008 Dec;10(6):495-8. doi: 10.1089/dia.2008.0013.

PMID:
19049379
[PubMed - indexed for MEDLINE]
19.

Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes.

Pickup JC, Renard E.

Diabetes Care. 2008 Feb;31 Suppl 2:S140-5. doi: 10.2337/dc08-s235. Review.

PMID:
18227475
[PubMed - indexed for MEDLINE]
20.

Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.

Wainstein J, Metzger M, Boaz M, Minuchin O, Cohen Y, Yaffe A, Yerushalmy Y, Raz I, Harman-Boehm I.

Diabet Med. 2005 Aug;22(8):1037-46.

PMID:
16026370
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk